Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a Canada-based specialty pharmaceutical company. The Company's principal business activity includes developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invested in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The Company's portfolio consists of pharmaceutical products with molecules and includes both in-licensed products, such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome as well as products owned (or partially owned) by it, such as Exelon and Impavido.


TSX:GUD - Post by User

Comment by porksnifferon Aug 18, 2021 10:43am
70 Views
Post# 33723110

RE:RE:RE:RE:RE:Analyst's Reports

RE:RE:RE:RE:RE:Analyst's Reports
Chianchin wrote: The same old dead cat bounce and soon back in the same dogs house $5.05. MNGT has failled to invest nearly a billion dollar and no profits eight Years later 



As predicted the one day bounce is done; this is going right back down to where it came from...where management will spend tens of millions more buying up shares to desperatly prevent a sub $5.00 price which would unleash even more selling. How are all the 'vlaue' investors doing? The bodies of posters who see 'value' are piling up, no doubt helped by Mr. Mugs fraudulant posts. You'll be lucky to get $5.50 when JRG and family take this turd private.
<< Previous
Bullboard Posts
Next >>